MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
| Official URL: https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/ValueSet/mii-vs-onko-weitere-klassifikationen-auspraegungen | Version: 2027.0.0-ballot.1 | |||
| Active as of 2026-09-15 | Computable Name: MII_VS_Onko_Weitere_Klassifikationen_Auspraegungen | |||
Copyright/Legal: This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of SNOMED International. All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. SNOMED and SNOMED CT are registered trademarks of SNOMED International. Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license. |
||||
Comprehensive collection of cancer staging systems and classification schemes used in oncology beyond TNM classification. This includes AJCC, FIGO, hematological classifications, and specialized organ-specific systems. Based on mCODE STU4 and German oBDS catalogue. Covers entity-specific classifications (e.g., FIGO for gynecological tumors), hematological classifications, and WHO classifications for CNS tumors.
References
This value set includes codes based on the following rules:
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a binethttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a ann-arbor-stadiumhttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a isshttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a isswmhttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a who-gradhttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a formenhttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a eln-klassifikationhttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a durie-salmon-stadiumhttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a figohttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a bismuthhttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a masaokahttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a mitoserate-gisthttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a p16https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a eutos-scorehttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a sanz-scorehttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a ipihttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a flipihttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a mipihttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a risikogruppen-ghsghttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a ipsshttps://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds version 📦2027.0.0-ballot.1 where concept is-a her2-neuhttp://snomed.info/sct version Not Stated (use latest from terminology server)
| Code | Display |
| 1290294004 | International Federation of Gynecology and Obstetrics grading system (qualifier value) |
| 1290302009 | International Federation of Gynecology and Obstetrics grading system grade 1 (qualifier value) |
| 1290303004 | International Federation of Gynecology and Obstetrics grading system grade 2 (qualifier value) |
| 1290304005 | International Federation of Gynecology and Obstetrics grading system grade 3 (qualifier value) |
Expansion from 127.0.0.1 based on:
This value set expansion contains 223 concepts.
| System | Code | Display (en) | Definition | JSON | XML |
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | binet | BINET Staging System | Staging system for chronic lymphocytic leukemia based on lymph node involvement and organ enlargement. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | binet-a | BINET A | Early stage CLL: lymphocytosis in blood and bone marrow only | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | binet-b | BINET B | Intermediate stage CLL: lymphocytosis with enlarged lymph nodes or spleen/liver | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | binet-c | BINET C | Advanced stage CLL: lymphocytosis with anemia or thrombocytopenia | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-stadium | Ann-Arbor Stadium | Staging system for Hodgkin and Non-Hodgkin lymphomas based on anatomical extent of disease. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-i | I | Single lymph node region or single extralymphatic organ | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ia | IA | Single lymph node region, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iae | IAE | Single lymph node region with extranodal extension, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ib | IB | Single lymph node region with B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ibe | IBE | Single lymph node region with extranodal extension and B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ie | IE | Single extralymphatic organ involvement | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ix | IX | Single lymph node region, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ixa | IXA | Single lymph node region, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ixae | IXAE | Single lymph node region with extranodal extension, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ixb | IXB | Single lymph node region, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ixbe | IXBE | Single lymph node region with extranodal extension, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ixe | IXE | Single extralymphatic organ, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii | II | Two or more lymph node regions on same side of diaphragm | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1 | II1 | Two lymph node regions on same side of diaphragm | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1a | II1A | Two lymph node regions on same side of diaphragm, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1ae | II1AE | Two lymph node regions on same side of diaphragm with extranodal extension, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1b | II1B | Two lymph node regions on same side of diaphragm with B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1be | II1BE | Two lymph node regions on same side of diaphragm with extranodal extension and B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1e | II1E | Two lymph node regions on same side of diaphragm with extranodal extension | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1x | II1X | Two lymph node regions on same side of diaphragm, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1xa | II1XA | Two lymph node regions on same side of diaphragm, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1xae | II1XAE | Two lymph node regions on same side of diaphragm with extranodal extension, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1xb | II1XB | Two lymph node regions on same side of diaphragm, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1xbe | II1XBE | Two lymph node regions on same side of diaphragm with extranodal extension, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii1xe | II1XE | Two lymph node regions on same side of diaphragm with extranodal extension, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2 | II2 | Multiple lymph node regions on same side of diaphragm | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2a | II2A | Multiple lymph node regions on same side of diaphragm, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2ae | II2AE | Multiple lymph node regions on same side of diaphragm with extranodal extension, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2b | II2B | Multiple lymph node regions on same side of diaphragm with B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2be | II2BE | Multiple lymph node regions on same side of diaphragm with extranodal extension and B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2e | II2E | Multiple lymph node regions on same side of diaphragm with extranodal extension | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2x | II2X | Multiple lymph node regions on same side of diaphragm, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2xa | II2XA | Multiple lymph node regions on same side of diaphragm, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2xae | II2XAE | Multiple lymph node regions on same side of diaphragm with extranodal extension, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2xb | II2XB | Multiple lymph node regions on same side of diaphragm, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2xbe | II2XBE | Multiple lymph node regions on same side of diaphragm with extranodal extension, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ii2xe | II2XE | Multiple lymph node regions on same side of diaphragm with extranodal extension, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iia | IIA | Two or more lymph node regions on same side of diaphragm, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiae | IIAE | Two or more lymph node regions on same side of diaphragm with extranodal extension, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iib | IIB | Two or more lymph node regions on same side of diaphragm with B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iibe | IIBE | Two or more lymph node regions on same side of diaphragm with extranodal extension and B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iie | IIE | Two or more lymph node regions on same side of diaphragm with extranodal extension | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iix | IIX | Two or more lymph node regions on same side of diaphragm, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iixa | IIXA | Two or more lymph node regions on same side of diaphragm, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iixae | IIXAE | Two or more lymph node regions on same side of diaphragm with extranodal extension, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iixb | IIXB | Two or more lymph node regions on same side of diaphragm, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iixbe | IIXBE | Two or more lymph node regions on same side of diaphragm with extranodal extension, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iixe | IIXE | Two or more lymph node regions on same side of diaphragm with extranodal extension, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iii | III | Lymph node regions on both sides of diaphragm | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiia | IIIA | Lymph node regions on both sides of diaphragm, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiiae | IIIAE | Lymph node regions on both sides of diaphragm with extranodal extension, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiiaes | IIIAES | Lymph node regions on both sides of diaphragm with extranodal extension and spleen involvement, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiias | IIIAS | Lymph node regions on both sides of diaphragm with spleen involvement, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiib | IIIB | Lymph node regions on both sides of diaphragm with B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiibe | IIIBE | Lymph node regions on both sides of diaphragm with extranodal extension and B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiibes | IIIBES | Lymph node regions on both sides of diaphragm with extranodal extension, spleen involvement, and B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiibs | IIIBS | Lymph node regions on both sides of diaphragm with spleen involvement and B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiie | IIIE | Lymph node regions on both sides of diaphragm with extranodal extension | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiies | IIIES | Lymph node regions on both sides of diaphragm with extranodal extension and spleen involvement | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiis | IIIS | Lymph node regions on both sides of diaphragm with spleen involvement | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiix | IIIX | Lymph node regions on both sides of diaphragm, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixa | IIIXA | Lymph node regions on both sides of diaphragm, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixae | IIIXAE | Lymph node regions on both sides of diaphragm with extranodal extension, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixaes | IIIXAES | Lymph node regions on both sides of diaphragm with extranodal extension and spleen involvement, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixas | IIIXAS | Lymph node regions on both sides of diaphragm with spleen involvement, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixb | IIIXB | Lymph node regions on both sides of diaphragm, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixbe | IIIXBE | Lymph node regions on both sides of diaphragm with extranodal extension, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixbes | IIIXBES | Lymph node regions on both sides of diaphragm with extranodal extension and spleen involvement, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixbs | IIIXBS | Lymph node regions on both sides of diaphragm with spleen involvement, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixe | IIIXE | Lymph node regions on both sides of diaphragm with extranodal extension, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixes | IIIXES | Lymph node regions on both sides of diaphragm with extranodal extension and spleen involvement, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iiixs | IIIXS | Lymph node regions on both sides of diaphragm with spleen involvement, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iii1 | III1 | Limited lymph node regions on both sides of diaphragm | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iii1a | III1A | Limited lymph node regions on both sides of diaphragm, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iii1b | III1B | Limited lymph node regions on both sides of diaphragm with B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iii2 | III2 | Multiple lymph node regions on both sides of diaphragm | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iii2a | III2A | Multiple lymph node regions on both sides of diaphragm, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iii2b | III2B | Multiple lymph node regions on both sides of diaphragm with B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iv | IV | Disseminated involvement of one or more extralymphatic organs | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-iva | IVA | Disseminated involvement of extralymphatic organs, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ivae | IVAE | Disseminated involvement of extralymphatic organs with additional extranodal extension, asymptomatic | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ivb | IVB | Disseminated involvement of extralymphatic organs with B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ivbe | IVBE | Disseminated involvement of extralymphatic organs with additional extranodal extension and B symptoms | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ive | IVE | Disseminated involvement of extralymphatic organs with extranodal extension | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ivx | IVX | Disseminated involvement of extralymphatic organs, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ivxa | IVXA | Disseminated involvement of extralymphatic organs, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ivxae | IVXAE | Disseminated involvement of extralymphatic organs with additional extranodal extension, symptoms unclear, asymptomatic features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ivxb | IVXB | Disseminated involvement of extralymphatic organs, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ivxbe | IVXBE | Disseminated involvement of extralymphatic organs with additional extranodal extension, symptoms unclear, B symptom features | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ann-arbor-ivxe | IVXE | Disseminated involvement of extralymphatic organs with extranodal extension, symptoms unclear | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | iss | International Staging System | Staging system for multiple myeloma based on serum beta-2 microglobulin and albumin levels. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | iss-i | ISS I | Beta-2 microglobulin <3.5 mg/L and albumin ≥3.5 g/dL | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | iss-ii | ISS II | Not ISS I or ISS III | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | iss-iii | ISS III | Beta-2 microglobulin ≥5.5 mg/L | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | isswm | International Scoring System for Waldenström's Macroglobulinemia | Prognostic scoring system for Waldenström's macroglobulinemia based on age, beta-2 microglobulin, and albumin levels. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | isswm-n | ISSWM Niedrig | Low risk: age ≤65 years, beta-2 microglobulin ≤3 mg/L, albumin >3.5 g/dL | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | isswm-i | ISSWM Intermediär | Intermediate risk: one adverse factor | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | isswm-h | ISSWM Hoch | High risk: age >65 years or beta-2 microglobulin >3 mg/L, or albumin ≤3.5 g/dL (≥2 factors) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | who-grad | WHO Grade | World Health Organization grading system for central nervous system tumors based on histological features. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | who-grad-i | WHO Grad I | Well-differentiated, slow-growing, low proliferative potential | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | who-grad-ii | WHO Grad II | Moderately differentiated, infiltrative, low proliferative potential | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | who-grad-iii | WHO Grad III | Poorly differentiated, anaplastic, high proliferative potential | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | who-grad-iv | WHO Grad IV | Poorly differentiated, high mitotic activity, necrosis, microvascular proliferation | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | formen | Formen | Classification of lymphoma forms distinguishing classical and variant presentations. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | formen-k | Klassisch | Classical form of lymphoma presentation | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | formen-v | Variante | Variant form of lymphoma presentation | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eln-klassifikation | ELN-Klassifikation | European LeukemiaNet risk stratification for acute myeloid leukemia based on cytogenetic and molecular genetic abnormalities. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eln-g | ELN Günstig | Favorable risk: good prognosis cytogenetic/molecular markers | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eln-i1 | ELN Intermediär I | Intermediate risk I: intermediate prognosis markers | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eln-i2 | ELN Intermediär II | Intermediate risk II: intermediate prognosis markers | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eln-u | ELN Ungünstig | Unfavorable risk: poor prognosis cytogenetic/molecular markers | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eln-cp | ELN Chronische Phase | Chronic phase (CML context) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eln-ap | ELN Akzelierte Phase | Accelerated phase (CML context) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eln-bk | ELN Blastenkrise | Blast crisis phase (CML context) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | durie-salmon-stadium | Durie-Salmon Stadium | Multiple myeloma staging system based on tumor burden and organ function. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | durie-salmon-i | Durie-Salmon I | Low tumor burden: hemoglobin >10 g/dL, calcium normal, no bone lesions | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | durie-salmon-ia | Durie-Salmon IA | Low tumor burden with normal renal function | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | durie-salmon-ib | Durie-Salmon IB | Low tumor burden with abnormal renal function | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | durie-salmon-ii | Durie-Salmon II | Intermediate tumor burden: neither stage I nor III criteria | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | durie-salmon-iia | Durie-Salmon IIA | Intermediate tumor burden with normal renal function | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | durie-salmon-iib | Durie-Salmon IIB | Intermediate tumor burden with abnormal renal function | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | durie-salmon-iii | Durie-Salmon III | High tumor burden: hemoglobin <8.5 g/dL, calcium elevated, extensive bone lesions | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | durie-salmon-iiia | Durie-Salmon IIIA | High tumor burden with normal renal function | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | durie-salmon-iiib | Durie-Salmon IIIB | High tumor burden with abnormal renal function | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo | FIGO | Staging system of the International Federation of Gynecology and Obstetrics (FIGO) for gynecological malignancies. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-i | FIGO I | Tumor confined to the organ of origin | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ia | FIGO IA | Stage I with limited local extent (entity-specific definition) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ia1 | FIGO IA1 | Stage IA, subgroup 1 (e.g. cervix: measured stromal invasion <3 mm) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ia2 | FIGO IA2 | Stage IA, subgroup 2 (e.g. cervix: measured stromal invasion 3 to <5 mm) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ia3 | FIGO IA3 | Stage IA, subgroup 3 (entity-specific definition) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ib | FIGO IB | Stage I with extended local extent (entity-specific definition) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ib1 | FIGO IB1 | Stage IB, subgroup 1 (e.g. cervix: invasive carcinoma <2 cm) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ib2 | FIGO IB2 | Stage IB, subgroup 2 (e.g. cervix: invasive carcinoma 2 to <4 cm) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ib3 | FIGO IB3 | Stage IB, subgroup 3 (e.g. cervix: invasive carcinoma 4 cm or larger) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ic | FIGO IC | Stage I with capsule rupture, surface involvement or malignant ascites | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ic1 | FIGO IC1 | Stage IC due to intraoperative surgical spill | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ic2 | FIGO IC2 | Stage IC due to preoperative capsule rupture or surface tumor | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ic3 | FIGO IC3 | Stage IC due to malignant cells in ascites or peritoneal washings | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ii | FIGO II | Tumor extending beyond the organ of origin within the pelvis | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iia | FIGO IIA | Stage II with limited extension (entity-specific definition) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iia1 | FIGO IIA1 | Stage IIA, subgroup 1 (e.g. cervix: lesion <4 cm) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iia2 | FIGO IIA2 | Stage IIA, subgroup 2 (e.g. cervix: lesion 4 cm or larger) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iib | FIGO IIB | Stage II with extended extension (entity-specific definition) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iic | FIGO IIC | Stage II with capsule rupture, surface involvement or malignant ascites (historical FIGO revisions) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iii | FIGO III | Tumor with extrapelvic peritoneal spread and/or regional lymph node involvement | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiia | FIGO IIIA | Stage III with microscopic or limited extrapelvic spread (entity-specific definition) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiia1 | FIGO IIIA1 | Stage III with retroperitoneal lymph node metastasis only | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiia1i | FIGO IIIA1(i) | Stage IIIA1 with lymph node metastasis 10 mm or smaller | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiia1ii | FIGO IIIA1(ii) | Stage IIIA1 with lymph node metastasis larger than 10 mm | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiia2 | FIGO IIIA2 | Stage III with microscopic extrapelvic peritoneal involvement | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiib | FIGO IIIB | Stage III with macroscopic extrapelvic peritoneal metastasis 2 cm or smaller | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiic | FIGO IIIC | Stage III with macroscopic extrapelvic peritoneal metastasis larger than 2 cm and/or regional lymph node metastasis | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiic1 | FIGO IIIC1 | Stage III with pelvic lymph node metastasis | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiic1r | FIGO IIIC1r | Stage IIIC1 established by imaging | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiic1p | FIGO IIIC1p | Stage IIIC1 established by pathology | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiic2 | FIGO IIIC2 | Stage III with para-aortic lymph node metastasis | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiic2r | FIGO IIIC2r | Stage IIIC2 established by imaging | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iiic2p | FIGO IIIC2p | Stage IIIC2 established by pathology | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iv | FIGO IV | Distant metastasis beyond the peritoneal cavity | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-iva | FIGO IVA | Stage IV with spread to adjacent pelvic organs or pleural effusion with positive cytology (entity-specific definition) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ivb | FIGO IVB | Stage IV with distant metastasis including extra-abdominal organs and lymph nodes | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | figo-ivc | FIGO IVC | Stage IV with distant metastasis (entity-specific definition) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | bismuth | Bismuth | Classification system for hilar cholangiocarcinoma based on the extent of biliary involvement and resectability. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | bismuth-i | Bismuth I | Tumor below confluence of left and right hepatic ducts | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | bismuth-ii | Bismuth II | Tumor reaching confluence but not involving secondary ducts | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | bismuth-iii | Bismuth III | Tumor involving confluence and either right or left secondary ducts | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | bismuth-iiia | Bismuth IIIA | Tumor involving confluence and right secondary ducts | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | bismuth-iiib | Bismuth IIIB | Tumor involving confluence and left secondary ducts | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | bismuth-iv | Bismuth IV | Tumor involving confluence and both right and left secondary ducts | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | masaoka | Masaoka | Staging system for thymomas based on invasiveness and extent of disease. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | masaoka-i | Masaoka I | Encapsulated tumor without invasion | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | masaoka-ii | Masaoka II | Invasion into surrounding fatty tissue or mediastinal pleura | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | masaoka-iii | Masaoka III | Invasion into neighboring organs | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | masaoka-iv | Masaoka IV | Pleural or pericardial dissemination | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | masaoka-iva | Masaoka IVA | Pleural or pericardial implants | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | masaoka-ivb | Masaoka IVB | Lymphogenous or hematogenous metastasis | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | mitoserate-gist | Mitoserate-GIST | Mitotic rate assessment for gastrointestinal stromal tumors. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | mitoserate-gist-n | Mitoserate-GIST Niedrig | Low mitotic rate: ≤5 mitoses per 50 HPF | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | mitoserate-gist-h | Mitoserate-GIST Hoch | High mitotic rate: >5 mitoses per 50 HPF | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | p16 | p16 | p16 protein expression status assessment. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | p16-p | p16 Positiv | Positive p16 protein expression | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | p16-n | p16 Negativ | Negative p16 protein expression | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eutos-score | EUTOS-Score | European Treatment and Outcome Study prognostic score for chronic myeloid leukemia. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eutos-score-n | EUTOS-Score Niedrigrisiko | Low risk EUTOS score: ≤87 | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | eutos-score-h | EUTOS-Score Hochrisiko | High risk EUTOS score: >87 | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | sanz-score | Sanz-Score | Risk assessment score for acute promyelocytic leukemia. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | sanz-score-n | Sanz-Score Niedrig | Low risk: WBC <10x10⁹/L and platelets >40x10⁹/L | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | sanz-score-i | Sanz-Score Intermediär | Intermediate risk: WBC <10x10⁹/L and platelets ≤40x10⁹/L | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | sanz-score-h | Sanz-Score Hoch | High risk: WBC ≥10x10⁹/L | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ipi | IPI | International Prognostic Index for aggressive non-Hodgkin lymphoma. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ipi-n | IPI Niedrig | Low risk: 0-1 risk factors | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ipi-ni | IPI Niedrig-Intermediär | Low-intermediate risk: 2 risk factors | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ipi-hi | IPI Hoch-Intermediär | High-intermediate risk: 3 risk factors | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ipi-h | IPI Hoch | High risk: 4-5 risk factors | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | flipi | FLIPI | Follicular Lymphoma International Prognostic Index. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | flipi-l | FLIPI Low risk | Low risk: 0-1 risk factors | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | flipi-i | FLIPI Intermediate risk | Intermediate risk: 2 risk factors | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | flipi-h | FLIPI High risk | High risk: ≥3 risk factors | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | mipi | MIPI | Mantle Cell Lymphoma International Prognostic Index. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | mipi-n | MIPI Niedrig | Low risk MIPI score | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | mipi-i | MIPI Intermediär | Intermediate risk MIPI score | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | mipi-h | MIPI Hoch | High risk MIPI score | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | risikogruppen-ghsg | Risikogruppen GHSG | German Hodgkin Study Group risk stratification. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | risikogruppen-ghsg-fr | GHSG Frühe | Early favorable risk group | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | risikogruppen-ghsg-i | GHSG Intermediär | Intermediate risk group | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | risikogruppen-ghsg-fo | GHSG Fortgeschritten | Advanced risk group | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ipss | IPSS | International Prognostic Scoring System for myelodysplastic syndromes. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ipss-l | IPSS Low | Low risk: score 0 | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ipss-i1 | IPSS Intermediate-I | Intermediate-1 risk: score 0.5-1.0 | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ipss-i2 | IPSS Intermediate-II | Intermediate-2 risk: score 1.5-2.0 | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | ipss-h | IPSS High risk | High risk: score ≥2.5 | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | her2-neu | HER2-neu | HER2-neu protein expression and gene amplification status. | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | her2-neu-p | HER2-neu Positiv | Positive HER2-neu status (IHC 3+ or FISH amplified) | ||
https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-weitere-klassifikationen-obds | her2-neu-n | HER2-neu Negativ | Negative HER2-neu status (IHC 0-1+ or FISH not amplified) | ||
http://snomed.info/sct | 1290294004 | International Federation of Gynecology and Obstetrics grading system (qualifier value) | |||
http://snomed.info/sct | 1290302009 | International Federation of Gynecology and Obstetrics grading system grade 1 (qualifier value) | |||
http://snomed.info/sct | 1290303004 | International Federation of Gynecology and Obstetrics grading system grade 2 (qualifier value) | |||
http://snomed.info/sct | 1290304005 | International Federation of Gynecology and Obstetrics grading system grade 3 (qualifier value) |